Back to companies

Instil Bio, Inc.

TILUSNASDAQPharmaceuticals & Healthcare

Instil Bio, Inc.

Revenue
—
FY2025
Operating income
-$78.6mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API